Nektar Therapeutics Corporation
Nektar Therapeutics develops therapeutics based on its advanced polymer conjugate chemistry technology platform.
Total Funding:
1200000000
Number Of Exists:
1
Employee Number:
501-1000
Funding Status:
IPO
Technology:
Biotechnology, Chemical, Health Care, Therapeutics
Estimated Revenue:
$50M to $100M
Founded Date:
1990
Acquisitions Number:
2.0
Industry:
Pharma
Headquarters:
San Carlos, California, United States
Last Funding Type:
Post-IPO Equity